JP2017503753A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503753A5 JP2017503753A5 JP2016532025A JP2016532025A JP2017503753A5 JP 2017503753 A5 JP2017503753 A5 JP 2017503753A5 JP 2016532025 A JP2016532025 A JP 2016532025A JP 2016532025 A JP2016532025 A JP 2016532025A JP 2017503753 A5 JP2017503753 A5 JP 2017503753A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- pharmaceutically acceptable
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C(C1)C(CC=C)OC(*)C1=O Chemical compound *C(C1)C(CC=C)OC(*)C1=O 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019125655A JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906133P | 2013-11-19 | 2013-11-19 | |
| US61/906,133 | 2013-11-19 | ||
| PCT/US2014/066458 WO2015077370A1 (en) | 2013-11-19 | 2014-11-19 | Anti-cancer agents and preparation thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019125655A Division JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017503753A JP2017503753A (ja) | 2017-02-02 |
| JP2017503753A5 true JP2017503753A5 (enExample) | 2017-12-28 |
| JP6937578B2 JP6937578B2 (ja) | 2021-09-22 |
Family
ID=53180106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016532025A Active JP6937578B2 (ja) | 2013-11-19 | 2014-11-19 | 抗癌剤およびその調製方法 |
| JP2019125655A Active JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019125655A Active JP6929903B2 (ja) | 2013-11-19 | 2019-07-05 | 抗癌剤およびその調製方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10000505B2 (enExample) |
| EP (1) | EP3071563B1 (enExample) |
| JP (2) | JP6937578B2 (enExample) |
| KR (1) | KR102428737B1 (enExample) |
| CN (3) | CN113461705A (enExample) |
| AU (1) | AU2014353087B2 (enExample) |
| BR (1) | BR112016011430B1 (enExample) |
| CA (1) | CA2931111C (enExample) |
| CL (1) | CL2016001209A1 (enExample) |
| DK (1) | DK3071563T3 (enExample) |
| EA (1) | EA035262B1 (enExample) |
| ES (1) | ES2943711T3 (enExample) |
| FI (1) | FI3071563T3 (enExample) |
| IL (2) | IL282430B2 (enExample) |
| MX (1) | MX375896B (enExample) |
| MY (1) | MY189459A (enExample) |
| PE (1) | PE20161240A1 (enExample) |
| PH (2) | PH12021551085A1 (enExample) |
| PT (1) | PT3071563T (enExample) |
| WO (1) | WO2015077370A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA035262B1 (ru) | 2013-11-19 | 2020-05-21 | Пюрдью Рисёрч Фаундейшн | Противораковые агенты и их получение |
| AU2017277786A1 (en) * | 2016-06-08 | 2019-01-03 | William Marsh Rice University | Derivatives of Thailanstatin A, methods of treatment and methods of synthesis thereof |
| CA3037883A1 (en) * | 2016-09-23 | 2018-03-29 | Purdue Research Foundation | Anti-cancer agents and preparation thereof |
| AU2018337815A1 (en) | 2017-09-20 | 2020-03-12 | Ph Pharma Co., Ltd. | Thailanstatin analogs |
| CN109020876A (zh) * | 2018-09-21 | 2018-12-18 | 大连理工大学 | 一种新型6-羟基-2h-二氢吡啶-3-酮的制备方法 |
| BR112021010936A2 (pt) | 2018-12-13 | 2021-08-31 | Eisai R&D Management Co., Ltd. | Conjugados anticorpo-fármaco de herboxidieno e métodos de uso |
| KR20220166828A (ko) * | 2020-04-09 | 2022-12-19 | 브리스톨-마이어스 스큅 컴퍼니 | 메야마이신 유사체 및 그의 사용 방법 |
| CN113563361B (zh) * | 2021-08-17 | 2022-05-20 | 浙江珲达生物科技有限公司 | 一种从伯克霍尔德菌发酵液提取fr901464的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR901464A (fr) | 1943-01-23 | 1945-07-27 | Boehringer & Soehne Gmbh | Procédé d'obtention de vanilline |
| US7825267B2 (en) * | 2006-09-08 | 2010-11-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Synthesis of FR901464 and analogs with antitumor activity |
| HUE035184T2 (en) | 2008-03-18 | 2018-05-02 | Genentech Inc | Combinations of an anti-HER2 antibody-drug conjugate and docetaxel |
| AR080234A1 (es) * | 2010-02-25 | 2012-03-21 | Marrone Bio Innovations Inc | Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo |
| KR101632806B1 (ko) * | 2011-08-27 | 2016-06-23 | 마론 바이오 이노베이션스, 인코포레이티드 | 부르크홀데리아 속의 단리된 박테리아 균주 및 그로부터의 살충 대사물-제제 및 용도 |
| CA2890569C (en) * | 2012-11-05 | 2019-03-05 | Pfizer Inc. | Spliceostatin analogs |
| EA035262B1 (ru) | 2013-11-19 | 2020-05-21 | Пюрдью Рисёрч Фаундейшн | Противораковые агенты и их получение |
-
2014
- 2014-11-19 EA EA201691010A patent/EA035262B1/ru not_active IP Right Cessation
- 2014-11-19 KR KR1020167016232A patent/KR102428737B1/ko active Active
- 2014-11-19 CN CN202110798232.6A patent/CN113461705A/zh active Pending
- 2014-11-19 DK DK14863201.1T patent/DK3071563T3/da active
- 2014-11-19 FI FIEP14863201.1T patent/FI3071563T3/fi active
- 2014-11-19 CN CN202110798234.5A patent/CN113773333A/zh active Pending
- 2014-11-19 BR BR112016011430-2A patent/BR112016011430B1/pt active IP Right Grant
- 2014-11-19 PE PE2016000653A patent/PE20161240A1/es unknown
- 2014-11-19 EP EP14863201.1A patent/EP3071563B1/en active Active
- 2014-11-19 JP JP2016532025A patent/JP6937578B2/ja active Active
- 2014-11-19 ES ES14863201T patent/ES2943711T3/es active Active
- 2014-11-19 PT PT148632011T patent/PT3071563T/pt unknown
- 2014-11-19 US US15/038,027 patent/US10000505B2/en active Active
- 2014-11-19 PH PH1/2021/551085A patent/PH12021551085A1/en unknown
- 2014-11-19 CN CN201480070416.9A patent/CN105829299A/zh active Pending
- 2014-11-19 MY MYPI2016000932A patent/MY189459A/en unknown
- 2014-11-19 IL IL282430A patent/IL282430B2/en unknown
- 2014-11-19 CA CA2931111A patent/CA2931111C/en active Active
- 2014-11-19 WO PCT/US2014/066458 patent/WO2015077370A1/en not_active Ceased
- 2014-11-19 AU AU2014353087A patent/AU2014353087B2/en active Active
- 2014-11-19 MX MX2016006591A patent/MX375896B/es active IP Right Grant
-
2016
- 2016-05-15 IL IL245637A patent/IL245637B/en active IP Right Grant
- 2016-05-19 CL CL2016001209A patent/CL2016001209A1/es unknown
- 2016-05-19 PH PH12016500924A patent/PH12016500924A1/en unknown
-
2019
- 2019-07-05 JP JP2019125655A patent/JP6929903B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017503753A5 (enExample) | ||
| MX2022008066A (es) | Compuestos triciclicos sustituidos. | |
| PH12022551014A1 (en) | Substituted tricyclic compounds | |
| PH12018550049A1 (en) | Protein kinase inhibitor, preparation method and medical use thereof | |
| JP2012530779A5 (enExample) | ||
| RU2012101947A (ru) | Способы лечения и профилактики усталости | |
| MX2013012588A (es) | Inhibidores de cinasa. | |
| JP2010138190A5 (enExample) | ||
| CA2637765A1 (en) | Benzamide and heteroarene derivatives | |
| RU2005109913A (ru) | Азабициклоалкильные эфиры и их применение в качестве агонистов альфа7-nachr | |
| JP2020514316A5 (enExample) | ||
| JP2015535247A5 (enExample) | ||
| JP2017524742A (ja) | テトラヒドロキノリン誘導体の調製のための合成中間体の調製方法 | |
| JP2017525765A (ja) | 新規イミノニトリル誘導体 | |
| KR101765956B1 (ko) | (＋)-1,4-다이하이드로-7-［(3ｓ,4ｓ)-3-메톡시-4-(메틸아미노)-1-피롤리딘일］-4-옥소-1-(2-티아졸릴)-1,8-나프티리딘-3-카복실산의 제조 방법 | |
| JOP20250057A1 (ar) | مركبات لعلاج السرطان | |
| BR112022010181A2 (pt) | Composto tri-heterocíclico como inibidor de jak e uso do mesmo | |
| EP4585269A3 (en) | Methods for cancer therapy | |
| NO20061319L (no) | 5-arylpyrimidiner som anticancer legemidler | |
| WO2008124823A1 (en) | Method of treating melanoma | |
| JP2017516829A5 (enExample) | ||
| CN103965175A (zh) | 4-(取代苯氨基)喹唑啉类化合物、其制备方法及应用 | |
| JP2013525290A5 (enExample) | ||
| JP2018140987A5 (enExample) | ||
| RU2010120810A (ru) | Гидратированные кристаллические сложные эфиры камптотецина для лечения рака |